Immunome, Inc. - Common Stock (NQ:IMNM)

18.21 -0.08 (-0.44%)

Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immunome, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Immunome Reports Second Quarter 2022 Financial Results

August 05, 2022

From Immunome, Inc.

Via Business Wire

Immunome's COVID-19 Cocktail Retains Neutralizing Activity Against Omicron Subvariants ↗

July 06, 2022

Via Benzinga

Immunome’s COVID-19 Cocktail Retains Neutralizing Activity Against the Most Prevalent Omicron Subvariants* in the US, BA.4/5 and BA.2.12.1

July 06, 2022

From Immunome, Inc.

Via Business Wire

Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19

June 09, 2022

From Immunome, Inc.

Via Business Wire

Short Volatility Alert: Immunome, Inc. ↗

May 24, 2022

On Modnay, shares of Immunome, Inc. (NASDAQ: IMNM) experienced volatile short activity. After the activity, the stock price went up +0.30% to $3.31. The overall sentiment for IMNM has been Bearish.

Via Benzinga

Immunome Shares Rise After Publishing Positive COVID-19 Antibody Cocktail Data ↗

May 19, 2022

Via Benzinga

Immunome: Q1 Earnings Insights ↗

May 12, 2022

Immunome (NASDAQ:IMNM) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday ↗

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

Immunome to Present at the Jefferies Healthcare Conference

June 02, 2022

From Immunome, Inc.

Via Business Wire

Recap: Immunome Q4 Earnings ↗

March 28, 2022

Immunome (NASDAQ:IMNM) reported its Q4 earnings results on Monday, March 28, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Immunome Provides Research & Development Update on Lead Oncology Candidate Targeting IL-38

May 23, 2022

From Immunome, Inc.

Via Business Wire

71 Biggest Movers From Yesterday ↗

May 20, 2022

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation...

Via Benzinga

Why Immunome Shares Are Rising ↗

May 19, 2022

Immunome Inc (NASDAQ: IMNM) shares are trading higher by 19.44% at $3.39 after the company published data demonstrating its COVID-19 antibody cocktail IMM-BCP-01 cleared the omicron variant of...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

May 19, 2022

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for...

Via Benzinga

Immunome Announces Data Demonstrating COVID-19 Antibody Cocktail Potently Clears Omicron BA.1 Variant in Hamster Model and Retains Activity Against BA.2 Subvariant

May 19, 2022

From Immunome, Inc.

Via Business Wire

Immunome Reports First Quarter 2022 Financial Results

May 12, 2022

From Immunome, Inc.

Via Business Wire

74 Biggest Movers From Yesterday ↗

April 29, 2022

Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric...

Via Benzinga

38 Stocks Moving In Wednesday's Mid-Day Session ↗

April 27, 2022

Gainers Vivakor, Inc. (NASDAQ: VIVK) gained 154% to $4.3550 after the company announced it has signed a 10-year contract with Hot Oil Transport with a potential value of...

Via Benzinga

Mid-Afternoon Market Update: Dow Drops 150 Points; Capricor Therapeutics Shares Plunge ↗

March 28, 2022

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 150 points on Monday.

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

March 28, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) jumped 57.1% to $1.96 following reports regarding potential future investments from AMC CEO, Adam Aron....

Via Benzinga

68 Biggest Movers From Yesterday ↗

April 19, 2022

Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; SAIC Profit Tops Views ↗

March 28, 2022

U.S. stocks traded mixed this morning, with the Dow dropping around 100 points on Monday.

Via Benzinga

50 Biggest Movers From Yesterday ↗

March 29, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in...

Via Benzinga

Immunome Reports Fourth Quarter and Full Year 2021 Financial Results

March 28, 2022

From Immunome, Inc.

Via Business Wire

Benzinga's After-Hours Movers & News: Recruiter.com, Waitr Holdings And More ↗

March 11, 2022

Benzinga’s “After-Hours Movers & News” highlights the biggest movers of the day. The information on the price action is collected using Benzinga Pro's...

Via Benzinga

58 Biggest Movers From Friday ↗

March 21, 2022

Gainers BEST Inc. (NYSE: BEST) shares gained 73.6% to close at $1.00. DiDi Global Inc. (NYSE: DIDI) shares jumped 59.8% to settle at $4.09 on Friday. Zhihu Inc. (NYSE: ZH)...

Via Benzinga

FDA Lifts Clinical Hold on Immunome's COVID-19 Candidate IND ↗

March 11, 2022

The FDA has lifted the clinical hold on Immunome Inc's (NASDAQ: IMNM) Investigational New Drug (IND) application for its antibody cocktail (IMM-BCP-01) to...

Via Benzinga

Immunome Shares Seesaw After COVID-19 Antibody Cocktail Works Against Live Omicron Virus ↗

February 08, 2022

Immunome Inc (NASDAQ: IMNM) shares rose before falling after reporting results from testing its experimental three-antibody cocktail

Via Benzinga

76 Biggest Movers From Yesterday ↗

March 08, 2022

Gainers Houston American Energy Corp. (NYSE: HUSA) surged 494.7% to close at $11.30 on Monday amid continued momentum and an increase in the price of oil. Imperial Petroleum Inc...

Via Benzinga

Immunome’s Antibody Cocktail Effective Against SARS-CoV-2 Omicron Variant in In Vitro Live Virus Testing

February 08, 2022

From Immunome, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.